An AllTrials project

NCT03425539: An ongoing trial by Idorsia Pharmaceuticals Ltd.

This trial is completed, but has been granted a delay in reporting its results. It must report results 3 months, 1 week ago.

Full data

Full entry on ClinicalTrials.gov NCT03425539
Title A Multicenter, dOuble-blind, ranDomized, Placebo-controlled, Parallel-group Study to Determine the effIcacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With FabrY Disease
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date June 21, 2018
Completion date Aug. 17, 2021
Required reporting date Aug. 17, 2024, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None